Exercise during CHemotherapy for Ovarian cancer (ECHO) trial: design and implementation of a randomised controlled trial.

Humans Female Quality of Life Australia Exercise Ovarian Neoplasms / drug therapy Exercise Therapy
GYNAECOLOGY ONCOLOGY PUBLIC HEALTH

Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
13 04 2023
Historique:
medline: 17 4 2023
entrez: 13 4 2023
pubmed: 14 4 2023
Statut: epublish

Résumé

Epidemiological evidence supports an association between higher levels of physical activity and improved cancer survival. Trial evidence is now needed to demonstrate the effect of exercise in a clinical setting. The Participants (target sample size: n=500) include women with newly diagnosed primary ovarian cancer, scheduled to receive first-line chemotherapy. Consenting participants are randomly allocated (1:1) to either the Ethics approval for the ECHO trial (2019/ETH08923) was granted by the Sydney Local Health District Ethics Review Committee (Royal Prince Alfred Zone) on 21 November 2014. Subsequent approvals were granted for an additional 11 sites across Queensland, New South Wales, Victoria and the Australian Capital Territory. Findings from the ECHO trial are planned to be disseminated via peer-reviewed publications and international exercise and oncology conferences. Australian New Zealand Clinical Trial Registry (ANZCTRN12614001311640; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=367123&isReview=true).

Identifiants

DOI: 10.1136/bmjopen-2022-067925 PMID: 37055210 PMC: PMC10106078
pubmed: 37055210
pii: bmjopen-2022-067925
doi: 10.1136/bmjopen-2022-067925
pmc: PMC10106078
doi:

Types de publication

Randomized Controlled Trial Clinical Trial, Phase III Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e067925

Investigateurs

Trudi Cattley (T)
James Nicklin (J)
Andrea Garrett (A)
Piksi Singh (P)
Jeff Goh (J)
Catherine Shannon (C)
Lewis Perrin (L)
Amasy Alkhateeb (A)
Dirkje Sommeijer (D)
Melissa Creed (M)
Sheree Rye (S)
Nicole McDonald (N)

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Psychiatry Res. 1989 May;28(2):193-213
pubmed: 2748771
J Sci Med Sport. 2019 Nov;22(11):1175-1199
pubmed: 31277921
Int J Gynecol Cancer. 2020 Nov;30(11):1784-1790
pubmed: 32727928
Gynecol Oncol. 2010 Nov;119(2):390-6
pubmed: 20594586
Gynecol Oncol. 2022 Feb;164(2):437-445
pubmed: 34955238
Breast Cancer Res Treat. 2018 Jan;167(2):505-514
pubmed: 29063309
Curr Med Res Opin. 2009 Oct;25(10):2487-94
pubmed: 19689221
J Obstet Gynecol Neonatal Nurs. 2017 Jul - Aug;46(4):544-554
pubmed: 28583482
J Natl Cancer Inst. 2013 Nov 6;105(21):1594-5
pubmed: 24108810
Ann Intern Med. 2013 Feb 5;158(3):200-7
pubmed: 23295957
BMC Cancer. 2011 Sep 08;11:389
pubmed: 21899778
Int J Gynecol Cancer. 2021 Apr;31(4):553-561
pubmed: 33462088
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
J Clin Oncol. 2001 Mar 15;19(6):1809-17
pubmed: 11251013
Med Sci Sports Exerc. 2019 Nov;51(11):2375-2390
pubmed: 31626055
Intern Med J. 2009 Aug;39(8):495-501
pubmed: 19732197
Qual Life Res. 2009 Sep;18(7):873-80
pubmed: 19543809
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
Gynecol Oncol. 2013 May;129(2):310-7
pubmed: 23403164
Lymphat Res Biol. 2020 Apr;18(2):101-109
pubmed: 31486709
Breast Cancer Res Treat. 2013 Jan;137(1):175-86
pubmed: 23139058
Curr Oncol. 2011 Oct;18 Suppl 2:S20-7
pubmed: 21969808
Med Sci Sports Exerc. 2014 Sep;46(9):1744-51
pubmed: 24633595
J Cancer Surviv. 2022 Aug;16(4):865-881
pubmed: 34510366
Gynecol Oncol. 2020 Oct;159(1):179-186
pubmed: 32773150
Expert Rev Pharmacoecon Outcomes Res. 2004 Oct;4(5):581-5
pubmed: 19807551
Respir Care. 2019 Oct;64(10):1261-1269
pubmed: 31270178
Semin Oncol Nurs. 2020 Oct;36(5):151075
pubmed: 33008685
Acta Oncol. 2001;40(2-3):340-60
pubmed: 11441940
J Am Geriatr Soc. 2006 May;54(5):743-9
pubmed: 16696738
Qual Life Res. 2011 Dec;20(10):1727-36
pubmed: 21479777
J Sci Med Sport. 2010 Sep;13(5):496-502
pubmed: 20005170
Int J Gynecol Cancer. 2011 Feb;21(2):419-23
pubmed: 21270624
Qual Life Res. 2018 Jan;27(1):59-74
pubmed: 29248998
JNCI Cancer Spectr. 2019 Oct 17;4(1):pkz080
pubmed: 32337494
N Engl J Med. 2011 Dec 29;365(26):2484-96
pubmed: 22204725
Int J Gynecol Cancer. 2014 Jun;24(5):865-73
pubmed: 24844220
Hematol Oncol Clin North Am. 2007 Oct;21(5):841-54
pubmed: 17908623
J Clin Oncol. 1993 Mar;11(3):570-9
pubmed: 8445433
Br J Cancer. 2008 Apr 8;98(7):1197-203
pubmed: 18349836
BMC Public Health. 2011 Jul 29;11:604
pubmed: 21798072
Contemp Clin Trials. 2011 Jul;32(4):577-85
pubmed: 21463707
Gynecol Oncol. 2020 Sep;158(3):803-811
pubmed: 32616402
J Pain Symptom Manage. 2002 Dec;24(6):547-61
pubmed: 12551804
Health Qual Life Outcomes. 2008 Jul 02;6:46
pubmed: 18597689
Ann Oncol. 2017 Apr 1;28(4):711-717
pubmed: 28327917
Lymphat Res Biol. 2018 Dec;16(6):559-566
pubmed: 30280970
Health Qual Life Outcomes. 2007 Dec 21;5:70
pubmed: 18154669
Drugs. 2017 May;77(7):713-719
pubmed: 28337673
J Exp Clin Cancer Res. 2009 Aug 19;28:116
pubmed: 19689822
Cancer Treat Rev. 2017 Jan;52:91-104
pubmed: 28006694
Nutrients. 2021 Nov 15;13(11):
pubmed: 34836345
Gynecol Oncol. 2020 Sep;158(3):760-768
pubmed: 32653100
Cancer Manag Res. 2014 Sep 22;6:365-71
pubmed: 25278784

Auteurs

Sandra Hayes (S)

School of Health Sciences and Social Work, Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia sandi.hayes@griffith.edu.au.
School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.
University of Sydney, NHMRC Clinical Trials Centre, Camperdown, New South Wales, Australia.
ORCID: 0000-0002-7005-5184

Andreas Obermair (A)

Queensland Centre for Gynaecological Cancer Research, University of Queensland, Brisbane, Queensland, Australia.

Linda Mileshkin (L)

Peter MacCallum Cancer Centre, Victoria, Australia.

Alison Davis (A)

Department of Medical Oncology, The Canberra Hospital and ANU Medical School, Australian National University, Canberra, Australian Capital Territory, Australia.

Louisa G Gordon (LG)

QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
ORCID: 0000-0002-3159-4249

Elizabeth Eakin (E)

School of Public Health, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

Monika Janda (M)

Centre for Health Services Research, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
ORCID: 0000-0002-1728-8085

Vanessa L Beesley (VL)

Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
School of Nursing, Queensland University of Technology, Brisbane, Queensland, Australia.
School of Public Health, University of Queensland, Brisbane, Queensland, Australia.

Elizabeth H Barnes (EH)

University of Sydney, NHMRC Clinical Trials Centre, Camperdown, New South Wales, Australia.

Rosalind Renee Spence (RR)

School of Health Sciences and Social Work, Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia.
ORCID: 0000-0002-5446-5562

Carolina Sandler (C)

School of Health Sciences and Social Work, Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia.
Sport and Exercise Science, School of Health Science, Western Sydney University, Sydney, New South Wales, Australia.

Tamara Jones (T)

School of Health Sciences and Social Work, Menzies Health Institute Queensland, Griffith University, Brisbane, Queensland, Australia.
School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.

Dimitrios Vagenas (D)

School of Public Health and Social Work, Queensland University of Technology, Brisbane, Queensland, Australia.

Penny Webb (P)

Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

John Andrews (J)

University of Sydney, NHMRC Clinical Trials Centre, Camperdown, New South Wales, Australia.

Alison Brand (A)

Department of Gynaecological Oncology, Westmead Hospital, Westmead, New South Waled and University of Sydney, Sydney, New South Wales, Australia.

Yeh Chen Lee (YC)

University of Sydney, NHMRC Clinical Trials Centre, Camperdown, New South Wales, Australia.
Prince of Wales Clinical School, Faculty of Medicine and Health, University of New South Wales, Randwick, New South Wales, Australia.

Michael Friedlander (M)

Prince of Wales Clinical School, Faculty of Medicine and Health, University of New South Wales, Randwick, New South Wales, Australia.

Kate Pumpa (K)

Research Institute for Sport and Exercise, University of Canberra, Canberra, Australian Capital Territory, Australia.

Helene O'Neille (H)

Consumer representatives, Brisbane, Queensland, Australia.

Merran Williams (M)

Consumer representatives, Brisbane, Queensland, Australia.

Martin Stockler (M)

University of Sydney, NHMRC Clinical Trials Centre, Camperdown, New South Wales, Australia.
ORCID: 0000-0003-3793-8724

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Exercise during CHemotherapy for Ovarian...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Mesures épidémiologiques › Démographie › État de santé › Qualité de vie › Exercise during CHemotherapy for Ovarian...
questionsmedicales.fr › Régions géographiques › Océanie › Australasie › Australie › Exercise during CHemotherapy for Ovarian...
questionsmedicales.fr › Activités humaines › Exercice physique › Exercise during CHemotherapy for Ovarian...
questionsmedicales.fr › Maladies endocriniennes › Troubles gonadiques › Maladies ovariennes › Tumeurs de l'ovaire › Exercise during CHemotherapy for Ovarian...
questionsmedicales.fr › Thérapeutique › Techniques de physiothérapie › Traitement par les exercices physiques › Exercise during CHemotherapy for Ovarian...